
Meet DxTerity
We are pioneering RNA-powered precision diagnostics to help healthcare providers better understand autoimmune diseases and empower patients to live healthier lives through informed, personalized care.
Insightful RNA-based testing for autoimmune diseases

FOCUSED ASSAY
Measures interferon pathway activity to identify SLE patients more likely to experience moderate to severe disease.
Learn more

Targeted PANEL ASSAY
Broad immune system analysis to better characterize disease and therapeutic response.
Learn more
Innovation across testing, collection, and product development—engineered for precision, built for scale.


CAP CLIA
Certified Lab

Blood Collection Products and Test Kits

ISO 13485 | Product Development Services
Innovation across testing, collection, and product development—engineered for precision, built for scale.
Contact Us
Stay in the know.
Get the latest updates and news.
DxTerity’s patient-focused mission is to bring the power of at-home RNA-based genomic monitoring to improve the management of immune-mediated diseases and overall patient well-being.

Meet DxTerity
We are pioneering RNA-powered precision diagnostics to help healthcare providers better understand autoimmune diseases and empower patients to live healthier lives through informed, personalized care.
Insightful RNA-based testing for autoimmune diseases

FOCUSED ASSAY
Measures interferon pathway activity to identify SLE patients more likely to experience moderate to severe disease.
Learn more

Targeted PANEL ASSAY
Broad immune system analysis to better characterize disease and therapeutic response.
Learn more
Innovation across testing, collection, and product development—engineered for precision, built for scale.


CAP CLIA
Certified Lab

Blood Collection Products and Test Kits

ISO 13485 | ProductDevelopment Services
Discover how RNA-based diagnostics can provide the insights you need for better autoimmune disease management
Contact Us
Stay in the know.
Get the latest updates and news.
DxTerity’s patient-focused mission is to bring the power of at-home RNA-based genomic monitoring to improve the management of immune-mediated diseases and overall patient well-being.